Get your Cancer Immunology, Immunotherapy paper right the first time: a ready-made structure with the right abstract and citations, so editors see your science, not formatting slips.
4.4
Authored by Sumalatha Gangadhar | Published on 3 August, 2026
Submitting to Cancer Immunology, Immunotherapy goes smoothly when your draft already matches the journal's own rules. Editors screen new manuscripts against the Cancer Immunology, Immunotherapy guide for authors before peer review, so formatting, structure, and required statements should be right on the first draft rather than repaired during upload. This template sets that structure up for you.
It is a manuscript shell aligned to Cancer Immunology, Immunotherapy. It covers front matter, the abstract the journal expects, a body organized to the journal's article types, and a reference list in the journal's required style. Confirm current scope and article types on the Cancer Immunology, Immunotherapy journal page before you draft.
Prepare the title, authors, affiliations, and ORCID iDs. Write the abstract to the journal's rule and word limit, organize the body to the article type, and apply the required reference style from the first citation. Complete every declaration (ethics, competing interests, funding, data availability) the Cancer Immunology, Immunotherapy guide for authors lists, and cite figures and tables in order.
The common failure modes are formatting or reference style that does not match the guide for authors, missing required statements, and an incomplete portal checklist. Clear all three against the Cancer Immunology, Immunotherapy guide for authors before you submit.
The shell mirrors what editorial staff check first: article-type fit, the abstract rules, required declarations, and the journal's reference style. For more detail see the author resources. When your draft is ready, upload it through the journal's submission system.
| Element | Cancer Immunol Immunother requirement |
|---|---|
| Abstract | 150 to 250 words. The abstract should not contain any undefined abbreviations or unspecified references. For clinical trials, trial registration number and date of registration must be included as the last line of the manuscript abstract. Letter to the Editors: no abstract |
| Main text | Original research articles: 4000 words, 45 references, 8 figures/3 tables limit. Brief research reports: 2000 words, 20 references, 4 figures/2 tables limit. Review: 4000 words, 40 references, 2 explanatory items (figure/table). Letter to the Editors: 750 words, no abstract, no keywords, 1 figure, 5 references maximum, 3 authors maximum. Meta-analysis Reviews: 3000 words, 100 references maximum. Editorials: 1200 words, 10 references, 1 figure or table. Section order: Introduction, Materials and Methods, Results, Discussion |
| Declarations | Ethics approval/consent as applicable; competing interests; funding; data availability |
| Figures/tables | Publication-ready; cited in order |
| Supplemental | Upload separately when used |
| Keywords | 4 to 6 keywords for indexing purposes. Letter to the Editors: no keywords |
| References | Numbered (citations in text identified by numbers in square brackets). Entries in the list numbered consecutively. Journal names abbreviated according to ISSN List of Title Word Abbreviations. LaTeX users can use bibliography style file sn-basic.bst. Vancouver-style numbered references |
| Peer review | Single-blind peer review (single-blind reviewing procedure as stated in the official guide) |
| Submission | submission.nature.com/new-submission/262/3 |
Read the Cancer Immunology, Immunotherapy guide for authors once before drafting and once before upload. Draft the abstract after results are stable. Set the reference style before adding citations. Keep a cover letter that states your contribution and fit to Cancer Immunology, Immunotherapy in under a page.
Skim two or three recent Cancer Immunol Immunother papers to calibrate depth and figure style. Make the novelty clear in the first two pages. Deposit data and code when the policy on the Cancer Immunology, Immunotherapy journal page requires it. Disclose any preprint or conference version with identifiers in the cover letter.
Do one focused pass against the Cancer Immunology, Immunotherapy guide for authors: scope, length, reference style, required declarations, and figure quality. Then submit through the journal's submission system.